<DOC>
	<DOCNO>NCT00315900</DOCNO>
	<brief_summary>The primary objective study assess relative efficacy Depakote ER Seroquel agitate behavior among veteran dementia diagnosis residing Department Veterans Affairs ( VA ) nursing home care unit ( NHCU ) . The secondary objective study assess relative tolerability Depakote ER Seroquel population . The primary hypothesis agitate dementia patient demonstrate significantly great reduction Cohen-Mansfield Agitation Inventory ( CMAI ) score treated Depakote ER compare treatment Seroquel .</brief_summary>
	<brief_title>Depakote Extended Release ( ER ) Versus Seroquel Agitated Behaviors Nursing Home Care Unit Patients With Dementia</brief_title>
	<detailed_description>This study prospective , single-center , randomize , double-blind , double-dummy , crossover trial Depakote ER vs. Seroquel agitate behavior among veteran dementia . After consent obtain washout period one week five half-lives taper ( necessary ) , 20 eligible patient randomize received one two treatment . The first DEPAKOTE ER , initiate 250 mg daily . The treatment Seroquel , start 25 mg BID . Both treatment co-administered placebo match drug ( preserve blinding ) . Using serial examination blind laboratory reporting , dos adjust clinical response achieve serum valproate level least 50 mcg/mL . After treatment period six week , patient cross treatment without washout ( dos adjust concurrently ) second six-week treatment period . The Cohen-Mansfield Agitation Inventory ( CMAI ) primary outcome measure . Secondary measure include Behavior Pathology Alzheimer 's Disease Rating Scale ( BEHAVE-AD ) ; Clinical Global Impression Scale - Severity ; Clinical Global Impression Scale - Improvement ; Barnes Akathisia Scale ( BAS ) ; Abnormal Involuntary Movements Scale ( AIMS ) . Outcome measure performed end six-week treatment period avoid carryover effect .</detailed_description>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>Veterans Males female Aged 55 older With diagnosis dementia ( either Alzheimer 's disease , vascular dementia , mixed Alzheimer 's vascular dementia ) Residing Tuscaloosa VA Medical Center ( TVAMC ) NHCU bed Admitted NHCU bed Tuscaloosa VA Medical Center Score &gt; 5 Functional Assessment Staging ( FAST ) scale Score &lt; 23 MiniMental State Examination Score &gt; 1 Behavior Pathology Alzheimer 's Disease Rating Scale ( BEHAVEAD ) global rating Total BEHAVEAD score &gt; 8 Agitation present ( history chart review ) least two week ( minimize chance enrol agitation due delirium ) . Diagnosis dementia cause condition either Alzheimer 's disease , vascular dementia , mixed Alzheimer 's vascular dementia History schizophrenia , bipolar disorder , schizoaffective disorder Untreated depressive anxiety disorder Untreated pain evident physical examination Known allergy hypersensitivity either study drug History epilepsy seizures Diagnosis liver disease significant abnormality liver function test Thrombocytopenia Diagnosis past history pancreatitis Past history neuroleptic malignant syndrome Comorbid condition would render taper current antipsychotic anticonvulsant unsafe History agitation unresponsive adequate previous trial either valproate quetiapine The patient identifiable guardian , decisionmaking proxy , next kin approach consent participate . The patient 's guardian , decisionmaking proxy , next kin withholds , grant , consent participate Patient judge ill participate</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Seroquel</keyword>
	<keyword>Depakote ER</keyword>
	<keyword>Nursing Home</keyword>
	<keyword>Quetiapine</keyword>
	<keyword>Divalproex ER</keyword>
	<keyword>Agitation</keyword>
</DOC>